Prime Medicine, Inc.: retained earnings or deficit
Retained earnings or deficit for Prime Medicine, Inc. Inspect selected reporting periods, original units and SEC filing links; download the financial history.
All Prime Medicine, Inc. financial histories
What this measure means
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
Exact concept: us-gaap:RetainedEarningsAccumulatedDeficit. Each value is a balance at the reporting date, not a flow earned over a year. Different units remain separate; no currency conversion or interpolation is applied.
Coverage of this history
Selected reporting periods run from 2021-12-31 to 2025-12-31. The SEC response was captured on 2026-09-21.
Selected filing history
| Period start | Period end | Value | Unit | Filed | Source filing |
|---|---|---|---|---|---|
| At date | 2025-12-31 | -888,354,000 | USD | 2026-03-03 | 10-K · 0001628280-26-013569 |
| At date | 2024-12-31 | -687,212,000 | USD | 2026-03-03 | 10-K · 0001628280-26-013569 |
| At date | 2023-12-31 | -491,330,000 | USD | 2025-02-28 | 10-K · 0001628280-25-008884 |
| At date | 2022-12-31 | -293,197,000 | USD | 2024-03-01 | 10-K · 0001628280-24-008116 |
| At date | 2021-12-31 | -171,376,000 | USD | 2023-03-09 | 10-K · 0001628280-23-007266 |
Related financial histories
- Prime Medicine, Inc.: total assets
- Prime Medicine, Inc.: total liabilities
- Prime Medicine, Inc.: stockholders equity
- Prime Medicine, Inc.: cash and cash equivalents
- Prime Medicine, Inc.: net income or loss
- Prime Medicine, Inc.: operating cash flow
- Prime Medicine, Inc.: capital expenditure payments
- Prime Medicine, Inc.: contract revenue excluding tax
- Prime Medicine, Inc.: financing cash flow
- Prime Medicine, Inc.: investing cash flow
- Prime Medicine, Inc.: basic weighted-average shares
- Prime Medicine, Inc.: diluted weighted-average shares
- Prime Medicine, Inc.: basic earnings per share
- Prime Medicine, Inc.: diluted earnings per share
- Prime Medicine, Inc.: income tax expense or benefit
- Prime Medicine, Inc.: net property, plant and equipment
- Prime Medicine, Inc.: share-based compensation expense
- Prime Medicine, Inc.: operating income or loss
- Prime Medicine, Inc.: current assets
- Prime Medicine, Inc.: current liabilities
- Prime Medicine, Inc.: current accounts payable
- Prime Medicine, Inc.: operating expenses
- Prime Medicine, Inc.: research and development expense
Inspect the source
- Entity
- Prime Medicine, Inc. / CIK 0001894562
- Captured
- 2026-09-21T17:33:47.152Z
- SEC response SHA-256
a6bef163d02549a849172fe49d43d367b748d4e33f23f3f9ba4f9ec4593d6a2a
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001894562.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))